Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Méndez-Luna

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|January 17, 2016
Understanding the molecular basis of agonist/antagonist mechanism of GPER1/GPR30 through structural and energetic analysesDavid Méndez-Luna, Martiniano Bello, José Correa-Basurto
Journal of Biomolecular Structure & Dynamics|December 19, 2018
Structural insight into the binding mechanism of ATP to EGFR and L858R, and T790M and L858R/T790 mutantsLucia Saldaña-Rivera, Martiniano Bello, David Méndez-Luna
The Journal of Steroid Biochemistry and Molecular Biology|March 10, 2019
Structural and energetic basis for novel epicatechin derivatives acting as GPER agonists through the MMGBSA methodMartiniano Bello, David Méndez-Luna, Viviana Sarmiento, et al.
International Journal of Molecular Sciences|May 14, 2025
Epicatechin Decreases <i>UCP2</i> Gene Expression in MDA-MB-231 Breast Cancer Cells by the Presence of a Regulatory Element in the PromoterFernando Pereyra-Vergara, Ivonne María Olivares-Corichi, Juan Pedro Luna-Arias, et al.
Scientific Reports|May 21, 2025
Preclinical approach of two novel tetrahydroquinoline derivatives targeting GPER and Bcl-2 for anti-glioblastoma therapyDavid Méndez-Luna, Loreley-Araceli Morelos-Garnica, José-Rubén García-Sánchez, et al.
Scientific Reports|October 20, 2023
In silico design and cell-based evaluation of two dual anti breast cancer compounds targeting Bcl-2 and GPERLoreley-A Morelos-Garnica, Sonia Guzmán-Velázquez, Itzia-I Padilla-Martínez, et al.
Current Medicinal Chemistry|March 1, 2026
Unveiling the Small Molecules Binding Site of CD36 Cell Surface Receptor Through Docking and Molecular Dynamics SimulationsNaomi Montes-Mondragón, Rosa Salgado-Brito, José-Rubén García-Sánchez, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 2, 2024
GPER binding site detection and description: A flavonoid-based docking and molecular dynamics simulations studyDavid Méndez-Luna, Sonia Guzmán-Velázquez, Itzia-Irene Padilla-Martínez, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 20, 2018
Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPEROscar J Zacarías-Lara, David Méndez-Luna, Gustavo Martínez-Ruíz, et al.
Gels (Basel, Switzerland)|August 28, 2025
Topical Meglumine Antimoniate Gel for Cutaneous Leishmaniasis: Formulation, Evaluation, and In Silico InsightsLilian Sosa, Lupe Carolina Espinoza, Alba Pujol, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Steroid Biochemistry and Molecular Biology|January 17, 2016
Understanding the molecular basis of agonist/antagonist mechanism of GPER1/GPR30 through structural and energetic analysesDavid Méndez-Luna, Martiniano Bello, José Correa-Basurto
Journal of Biomolecular Structure & Dynamics|December 19, 2018
Structural insight into the binding mechanism of ATP to EGFR and L858R, and T790M and L858R/T790 mutantsLucia Saldaña-Rivera, Martiniano Bello, David Méndez-Luna
The Journal of Steroid Biochemistry and Molecular Biology|March 10, 2019
Structural and energetic basis for novel epicatechin derivatives acting as GPER agonists through the MMGBSA methodMartiniano Bello, David Méndez-Luna, Viviana Sarmiento, et al.
International Journal of Molecular Sciences|May 14, 2025
Epicatechin Decreases <i>UCP2</i> Gene Expression in MDA-MB-231 Breast Cancer Cells by the Presence of a Regulatory Element in the PromoterFernando Pereyra-Vergara, Ivonne María Olivares-Corichi, Juan Pedro Luna-Arias, et al.
Scientific Reports|May 21, 2025
Preclinical approach of two novel tetrahydroquinoline derivatives targeting GPER and Bcl-2 for anti-glioblastoma therapyDavid Méndez-Luna, Loreley-Araceli Morelos-Garnica, José-Rubén García-Sánchez, et al.
Scientific Reports|October 20, 2023
In silico design and cell-based evaluation of two dual anti breast cancer compounds targeting Bcl-2 and GPERLoreley-A Morelos-Garnica, Sonia Guzmán-Velázquez, Itzia-I Padilla-Martínez, et al.
Current Medicinal Chemistry|March 1, 2026
Unveiling the Small Molecules Binding Site of CD36 Cell Surface Receptor Through Docking and Molecular Dynamics SimulationsNaomi Montes-Mondragón, Rosa Salgado-Brito, José-Rubén García-Sánchez, et al.
The Journal of Steroid Biochemistry and Molecular Biology|February 2, 2024
GPER binding site detection and description: A flavonoid-based docking and molecular dynamics simulations studyDavid Méndez-Luna, Sonia Guzmán-Velázquez, Itzia-Irene Padilla-Martínez, et al.
Anti-Cancer Agents in Medicinal Chemistry|November 20, 2018
Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPEROscar J Zacarías-Lara, David Méndez-Luna, Gustavo Martínez-Ruíz, et al.
Gels (Basel, Switzerland)|August 28, 2025
Topical Meglumine Antimoniate Gel for Cutaneous Leishmaniasis: Formulation, Evaluation, and In Silico InsightsLilian Sosa, Lupe Carolina Espinoza, Alba Pujol, et al.
Pageof 2